News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Leo Mascarenhas: Elective Discontinuation of Larotrectinib in Pediatric Patients with TRK Fusion Sarcomas
Leo Mascarenhas/cedars-sinai.org
Jan 29, 2025, 12:53

Leo Mascarenhas: Elective Discontinuation of Larotrectinib in Pediatric Patients with TRK Fusion Sarcomas

Leo Mascarenhas, Division Chief and Director of Pediatric Hematology and Oncology at Cedars-Sinai Guerin Children, shared an article on LinkedIn:

“Hot of the press!

Some insight into the implications of stopping treatment in young sarcoma patients!”

Elective Discontinuation of Larotrectinib in Pediatric Patients With TRK Fusion Sarcomas and Related Mesenchymal Tumors.

Authors: Leo Mascarenhas, et al.

Leo Mascarenhas: Elective Discontinuation of Larotrectinib in Pediatric Patients with TRK Fusion Sarcomas

cancer Cedars-Sinai Guerin Children fight against cancer Global fight against cancer Hematology larotrectinib Leo Mascarenhas Mesenchymal Tumors OncoDaily Oncology
Special Coverage
Blog
May 18, 2025, 11:13
Talha Badar: Ph-Positive Acute Lymphoblastic Leukemia — 25 Years of Progress
Blog
May 18, 2025, 11:12
Pablo Mando: Honored and Privileged to Have Been Part of the Faculty of BCY at ESMO Breast 2025
Science
May 18, 2025, 10:59
Nina Niu Sanford: FOLFIRINOX vs. Single Agent Gemcitabine in Locally Advanced Pancreas Cancer
Blog
May 18, 2025, 10:58
Jame Abraham: Thank you, Canton Community, for Supporting Women Undergoing Cancer Treatment
Science
May 18, 2025, 10:44
Yan Leyfman: JAMA Study on Cancer Risks from CT Scans
Blog
May 18, 2025, 10:23
Anthony El-Khoueiry: Starting The Los Angeles Cholangiocarcinoma Symposium
Blog
May 18, 2025, 10:14
Drew Moghanaki: HORIZON-01 - ChemoRadiotherapy followed by Alectinib, Entrectinib, or Pralsetinib
Blog
May 18, 2025, 10:01
Martin Zapata Joins Key Voices in Prostate Cancer Discussion
Insight
May 18, 2025, 09:57
Understanding and Prioritizing Cancer Prevention in Women on Women's Health Week – Medicaid Cancer Foundation
Opinion
May 18, 2025, 09:54
Ashraf Saad: Fenretinide Induces Cytotoxicity in GATA1+ Erythroid and Megakaryoblastic Leukemia
Blog
May 18, 2025, 09:44
The Myeloma Minute is Out - International Myeloma Foundation
Blog
May 18, 2025, 09:43
Oncology Brothers: Less than 2 weeks to ASCO25